Aeon lowers warrant exercise price to $0.20

Aeon Biopharma amended its two-year milestone warrants to lower the exercise price for common stock to $0.20, supported by holders representing at least 67% of the potential shares. This corporate action was filed with the SEC on November 2, 2026.